Replies to post #136367 on Innovation Pharmaceuticals Inc (IPIX)

[TheDane]

Thanks, farrell!!! This presentation is much more then I anticipated.

[Phoenix300]

That's a great start

[thefamilyman]

Well done! Thanks.

[Ringrock]

thanks farrell!

Go Ctix!

[frrol]

Well done bud, thank you. So they're still planning an AML trial for Kevetrin; that's good. Like retinoblastoma and ovarian, AML is a natural indication for a P53 activator.

[cabel]

Thanks Farrell90!! Great summary!

[DaubersUP]

I enjoyed the 2 FACTS on why K is so valuable ($$$$$)
1) the ease of manufacturing
2) the fact it is not just a stand-alone drug. It has been proven to be effective in combo therapies.

Those two facts are very undervalued and I'm happy Dr J made a point to explain why they feel K is so valuable.

[slcimmuno]

Thx -- nice helpful recap

[CallMeCrazy]

I think you summarized the presentation quite well. However, your summary of the below quote left off an important point:

-lower BP than Daptomycin in trial
[and Daptomycin is not associated with high BP]

Thanks for a great summary.

Message in reply to:

Summary of presentation

Very professional ,well documented presentation by Dr Jorgensen

High point was the narrative which clarified management's future plans for their products.Several new points delivered.

Leo's introduction...Presentation outlines path to a multibillion dollar company.

Brilacidin

-new class of antibiotics
-lower risk of resistance due to multiple factors including new class, - single dose, short half life
-single dose makes follow up visits less critical
-effective against stationary and rapidly dividing bacteria and biofilm
-rapid clearing of bacteria is also a factor in lowering risk of resistance
-clinical response in 48-72 hrs
-QIDP approved
-SAE's reduced with lower dose, which proved to be effective
-lower BP than Daptomycin in trial

[windansea]

RE: Brilacidin

rapid clearing of bacteria is also a factor in lowering risk of resistance

I have no medical background, but to me,the above statement refers to the development resistance that would happen within the body of he person being treated. What happens to the oral rinses and enema solutions that being used in B-OM and B-UP? Are the rinses being spit into sinks and the enemas flushed down toilets? If this is the case, isn't our precious Brilacidin being introduced into public sewage systems to mingle with the gazillion badass bacteria that thrive in such places? I hope that CTIX has created a protocol which is part of our trials to carefully dispose of Brilacidin carrying waste in a manner that does not promote the development of resistance.

http://consumersunion.org/news/the-overuse-of-antibiotics-in-food-animals-threatens-public-health-2/